# Early Therapy Response Monitoring in Melanoma Patients Using PET/MRI

> **NCT03132090** · NA · UNKNOWN · sponsor: **University Hospital Tuebingen** · enrollment: 106 (estimated)

## Conditions studied

- Malignant Melanoma Stage IV

## Interventions

- **DIAGNOSTIC_TEST:** PET/MR (Biograph mMR)

## Key facts

- **NCT ID:** NCT03132090
- **Lead sponsor:** University Hospital Tuebingen
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-09-29
- **Primary completion:** 2018-01
- **Final completion:** 2018-06
- **Target enrollment:** 106 (ESTIMATED)
- **Last updated:** 2017-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03132090

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03132090, "Early Therapy Response Monitoring in Melanoma Patients Using PET/MRI". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03132090. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*